Physiology of the Female Pelvis Flashcards
1
Q
oral contraceptives
A
- inhibits ovulation and changes endo lining and cervical mucus
- contain estrogen and progesterone
- ovulatory phase should not occur
- nondominant follicles may be present
- endo appears as a thin echogenic line
2
Q
luteinizing hormone
A
- essential in both males and females for reproduction
- secreted by the anterior pituitary gland
- increasing estrogen levels stimulate LH production
- increase triggers ovulation and initiates the conversion of the residual follicle into a corpus luteum. corpus luteum produces progesterone to prepare the endo for possible implantation
- LH surge typically lasts only 48 hours
3
Q
LH releasing factor
A
becomes active after puberty
produced by the hypothalamus
released into the bloodstream, reaching the anterior pituitary gland
4
Q
luteinizing hormone
A
hormone that stimulates ovulation
5
Q
FSH releasing factor
A
- becomes active before puberty
- produced by the hypothalamus
- released into the bloodstream, reaching the anterior pituitary gland
- low levels of estrogen stimulates FSH production
6
Q
follicle stimulating hormone
A
- initiates follicular growth and stimulates the maturation of the graafian follicles
- secreted by anterior pituitary gland
- levels low in childhood and slightly higher after menopause
- levels decline in late follicular phase and slight increase at end of luteal phase
7
Q
corpus albcians
A
scar from previous corpus luteum
asymptomatic
hyperechoic focus within the ovary
differential: cystic teratoma
8
Q
proliferation phase of the endo
A
- overlaps the postmenstruation phase and occurs from days 6-14
- increasing estrogen levels regenerates the functional layer
- coincides with the follicular phase of the ovary
- early phase 4-6mm
- late phase 6-10mm
9
Q
luteal phase of the ovary
A
- days 15-28
- corpus luteum grows for 7-8 days, secreting some estrogen and an increasing amount of progesterone
- if ovum is fertilized, the corpus luteum will continue to secrete progesterone
- if fertilization does not occur, corpus luteum regresses after 9 days and progesterone levels decrease
10
Q
postmenopause without hormone replacement
A
- uterus generally decreases in length and width
- endo thickness should not exceed 8mm in asymptomatic patients or 5mm with vaginal bleeding
- ovaries atrophy and may be difficult to visualize
- decrease in estrogen can shorten the vagina and decreasecervical mucus
11
Q
amenorrhea
A
absence of menstruation
12
Q
endometrium
A
- thickness should not exceed 14 mm
- thickness of the postmenopausal endo without hormone replacement therapy should not exceed 8mm and is consistently benign when measuring 5mm or less
- fluid within the endo cavity is not included in the measurement of the endo thickness
13
Q
mittelschmerz
A
used to describe pelvic pain preceding ovulation
14
Q
ovulatory phase of the ovary
A
- occurs at the rupture of the graafian follicle-day 14
- pelvic pain increases over the ovulatory ovary (mittelschmerz)
- minimal amount of cul-de-sac fluid
15
Q
estrogen
A
- primary female sex hormone
- naturally occuring estrogens include estradiol, estroil, and estrone
- primarily produced by developing follicles and the placenta
- FSH and luteinizing hormone stimulate the production of estrogen in ovaries
- breast, liver, and adrenal glands produce small amounts
- promotes secondary sex characteristics, accelerates growth in height and metabolism, reduces muscle mass, stimulates endo growth and proliferation, and increases uterine growth